Kidney Health Initiative (KHI)

KHI Current Project

Advancing Technologies to Facilitate Remote Management of Patient Self-Care in Renal Replacement Therapy (RRT)

Patient Care Issue:

Digital and mobile-based technologies present new and possibly better disease management options for patients and healthcare professionals. These technologies hold the potential of improving outcomes through individualized patient-centered education, remote communication and data exchange, in-home clinical guidance, prescription/treatment adherence or changes, and a rapid alert system for health professionals. This responsiveness empowers patients and family care providers and has the potential to increase the number of patients receiving home-based therapies.


There is uncertainty regarding the approval of advanced medical devices, accessories, software, and mobile medical applications for consumer use. Reimbursement policies vary significantly across Medicaid, Medicare, and commercial insurance. This regulatory and payer misalignment and the knowledge gap is hindering patient access to technologies and services that have potential to improve outcomes for patients on home based therapies.

KHI Solution:

KHI assembled a workgroup tasked with addressing the state of remote monitoring wireless health/telemedicine technology that can be utilized to treat patients with kidney disease and assessing potential clinical and economic value. This information will be used to address key regulatory, legal, legislative, and reimbursement barriers affecting the adoption and usage of such technologies. The workgroup will develop a white paper and present their findings at workshop.


The workgroup has broken the topic into four areas- nomenclature, patient perspective, clinical/ provider perspective and regulatory perspective. They have outlined for papers and are in the midst of finalizing the content in order to submit to publication.


White paper and workshop that addresses the state of remote monitoring and telemedicine technology that can be utilized to treat patients with ESRD and renal illness.

Timeline for Completion:

Fall 2016.

KHI Workgroup:

Patrick Brophy, MD (Workgroup Co-chair)
University of Iowa Carver College

Susie Lew, MD (Workgroup Co-chair)
George Washington University


Paul Conway
American Association of Kidney Patients

Jennifer Ehrlich, RN, BSN, CDN
University of Iowa Children's Hospital

Robert Jarrin, JD
Qualcomm, Inc.

Uptal Patel, MD
Gilead Sciences, Inc.

Karen Rheuban, MD
University of Virginia

R. Brooks Robey, MD, FASN
Geisel School of Medicine at Dartmouth and
U.S. Department of Veterans Affairs

Mitchell Rosner, MD, FASN
University of Virginia

Neal Sikka, MD
George Washington University

Eric L. Wallace, MD, FASN
University of Alabama at Birmingham

KHI Board of Directors Liaison:

James A. Sloand, MD, FASN
Baxter International, Inc.

Conflict of Interest:

To view KHI’s Conflict of Interest and Disclosure Policy, please click here.

To view the Workgroup's Disclosures, please click here.

If you have any questions, please do not hesitate to contact KHI at